Millennium Management’s Milestone Pharmaceuticals MIST Stock Holding History

Millennium Management’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.21M	Buy	3,142,219 +1,597,894	+103%	+$2.55M	﹤0.01%	3154
2026 Q1	$1.84M	Buy	1,544,325 +1,141,690	+284%	+$2M	﹤0.01%	3948
2025 Q4	$813K	Buy	402,635 +1,076	+0.3%	+$2.32K	﹤0.01%	4628
2025 Q3	$803K	Buy	+401,559	New	+$706K	﹤0.01%	4780
2025 Q2	–	Sell	-322,082	Closed	-$258K	–	6166
2025 Q1	$258K	Sell	322,082 -2,381,177	-88%	-$4.73M	﹤0.01%	5174
2024 Q4	$6.38M	Sell	2,703,259 -75,266	-3%	-$129K	﹤0.01%	2607
2024 Q3	$4.22M	Buy	2,778,525 +28,595	+1%	+$41.6K	﹤0.01%	2994
2024 Q2	$3.66M	Sell	2,749,930 -105,682	-4%	-$170K	﹤0.01%	3016
2024 Q1	$5.11M	Buy	2,855,612 +1,361,123	+91%	+$2.21M	﹤0.01%	2845
2023 Q4	$2.5M	Sell	1,494,489 -200,802	-12%	-$545K	﹤0.01%	3423
2023 Q3	$5.26M	Sell	1,695,291 -55,877	-3%	-$174K	﹤0.01%	2631
2023 Q2	$4.99M	Buy	1,751,168 +22,146	+1%	+$83.5K	﹤0.01%	2673
2023 Q1	$6.81M	Sell	1,729,022 -266,007	-13%	-$972K	﹤0.01%	2321
2022 Q4	$7.9M	Buy	1,995,029 +1,061,931	+114%	+$5.59M	﹤0.01%	2383
2022 Q3	$8.57M	Sell	933,098 -425,264	-31%	-$3.23M	0.01%	2335
2022 Q2	$8.07M	Buy	1,358,362 +69,439	+5%	+$427K	0.01%	2290
2022 Q1	$8.28M	Buy	1,288,923 +303,056	+31%	+$1.89M	﹤0.01%	2365
2021 Q4	$6.46M	Buy	985,867 +290,626	+42%	+$1.74M	﹤0.01%	2637
2021 Q3	$3.97M	Sell	695,241 -23,389	-3%	-$132K	﹤0.01%	3137
2021 Q2	$3.95M	Buy	718,630 +833	+0.1%	+$4.72K	﹤0.01%	3075
2021 Q1	$4.16M	Buy	717,797 +2,011	+0.3%	+$14.7K	﹤0.01%	2781
2020 Q4	$4.8M	Buy	715,786 +408,032	+133%	+$2.73M	﹤0.01%	2486
2020 Q3	$2.25M	Buy	+307,754	New	+$2.21M	﹤0.01%	2508
2020 Q2	–	Sell	-191,858	Closed	-$353K	–	4432
2020 Q1	$353K	Buy	191,858 +162,364	+550%	+$2.81M	﹤0.01%	3081
2019 Q4	$472K	Buy	29,494 +5,790	+24%	+$102K	﹤0.01%	3418
2019 Q3	$410K	Sell	23,704 -10,495	-31%	-$207K	﹤0.01%	3383
2019 Q2	$929K	Buy	+34,199	New	+$705K	﹤0.01%	2851

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Millennium Management's MIST Position: Q2 2026 in Review

Millennium Management increased its Milestone Pharmaceuticals (MIST) stake by 103% in Q2 2026, buying an estimated $2.55M and bringing the position to 3,142,219 shares worth $4.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3154.

Millennium Management first reported a position in MIST in Q2 2019 and has held it in 27 quarters since. The position peaked at $8.57M in Q3 2022. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Millennium Management held 3,142,219 shares of Milestone Pharmaceuticals worth $4.21M as of Q2 2026.
Millennium Management bought 1,597,894 Milestone Pharmaceuticals shares in Q2 2026, an estimated $2.55M.
Milestone Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q2 2026, its #3154 holding.
Millennium Management first reported a position in Milestone Pharmaceuticals in Q2 2019 and has held it in 27 quarters since.
Millennium Management's Milestone Pharmaceuticals position peaked at $8.57M in Q3 2022.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.